Forte Biosciences Inc <FBRX.O>: Barclays initiates coverage with overweight rating and target price $74
FBRX•Related News
Tema Photonics & Optical ETF Adds Anthropic As Top Holding
LAZR•
Copper touches one-month high on Chinese shortages, eroding inventories
CPER•
LIVE MARKETS-No Zillennials, your rent isn't too damn high
SPY•
AST SpaceMobile closes USD 1.15 billion convertible senior notes offering due 2034
ASTS•
Hasbro up after raising annual sales, profit forecasts
HAS•